Vaxcyte Inc. share price logo

Vaxcyte Inc.

NASDAQ: PCVX

Mid Cap

$51.44

+0.77

(+1.52%)

as on

Vaxcyte Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $50.24
    $53.48
    downward going graph

    2.33%

    Downside

    3.97%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $29.08
    $65.00
    downward going graph

    43.47%

    Downside

    26.36%

    Upside

    downward going graph

Vaxcyte Inc. share price movements today

Previous Close
$50.67
Open
$51.60
Volume
976.8K
Day's Low - High
$50.24 - $53.48
52 Week Low - High
$29.08 - $65.00

Vaxcyte Inc. Historical Returns

1 Month Return
+ 5.45 %
3 Month Return
-4.71 %
1 Year Return
+ 54.01 %
3 Year Return
+ 0.57 %
5 Year Return
+ 139.48 %

Vaxcyte Inc. Stock Fundamentals & Key Indicators

Check Vaxcyte Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.3B

EPS (TTM)

-8.4829

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-1.1B

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-30.55%

Vaxcyte Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vaxcyte Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Vaxcyte Inc. image
Vaxcyte Inc.
BUY$7.3B139.48%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Vaxcyte Inc. Stock including INR - Dollar returns

The Vaxcyte Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vaxcyte Inc. investment value today

Current value as on today

₹1,67,259

Returns

₹67,259

(+67.26%)

Returns from Vaxcyte Inc. Stock

₹54,012 (+54.01%)

Dollar Impact

₹13,247 (+13.25%)

Analyst Recommendation on Vaxcyte Inc. Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Vaxcyte Inc.. Average target price of $109

Vaxcyte Inc. Share Price Target

Get share price movements and forecasts by analysts on Vaxcyte Inc..

What analysts predicted

52.81%UPSIDE

Target Price

$109

Current Price

$51.44

Analyzed by

15 Analysts

Target

$109.00

Vaxcyte Inc. target price $109, a slight upside of 52.81% compared to current price of $51.44. According to 15 analysts rating.

Indian Investors' Interest in Vaxcyte Inc. Stock

Search interest for Vaxcyte Inc. Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:32% versus previous 30 day period

Vaxcyte Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
14
-
-
-
-
-
-
-
-
-
Gross Profit
11
-3
-3
-4
-
-
-4
-
4
-5
Operating Income
-196
-114
-152
-139
-162
-180
-226
-242
-274
-345
EBITDA
-177
-91
-125
-135
-52
-135
-161
-209
-234
-314
Interest Expense
10
-
-
-
-
-
-
-
-
-
Depreciation
2
3
3
4
4
4
4
5
9
5
Income Before Tax
-180
-95
-128
-103
-137
-140
-166
-212
-246
-320
Income Tax Expense
14
-19
-
-4
-
-
-
-
-
-
Net Income
-180
-95
-128
-103
-137
-140
-166
-212
-246
-320
Net Profit Margin
-1251.56%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vaxcyte Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-1
-1
-1
-1
-9
-75
-15
-
Operating Income
-35
-54
-89
-103
-232
-468
-569
-923
EBITDA
-28
-49
-87
-96
-214
-392
-448
-741
Interest Expense
0
0
0
0
0
-
-
-
Depreciation
1
1
1
3
9
10
15
24
Income Before Tax
-29
-50
-89
-100
-223
-402
-463
-766
Income Tax Expense
6
3
-1
0
16
-402
-
-
Net Income
-29
-50
-89
-100
-223
-402
-463
-766
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vaxcyte Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-95
-128
-103
-137
-140
-166
-212
-246
-320
Operating Cash Flow
-159
-121
-60
-111
-166
-121
-143
-224
-280
Investing Cash Flow
-451
-80
-917
-557
123
77
121
115
-233
Financing Cash Flow
818
110
1,515
4
0
2
-3
2
601
Change in Cash
214
-92
531
-662
-41
-40
-25
-107
86

Vaxcyte Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-50
-89
-100
-223
-402
-463
-766
Operating Cash Flow
-30
-47
-46
-121
-170
-296
-452
-655
Investing Cash Flow
-1
-1
-1
-212
74
-773
-2,005
437
Financing Cash Flow
62
41
374
17
861
639
2,448
2
Change in Cash
29
-7
327
-316
765
-436
-9
-213

Global Institutional Holdings in Vaxcyte Inc.

Funds
Holdings
Jennison Associates LLC
1.18%
HHG PLC
11.48%
Geode Capital Management, LLC
2.22%
State Street Corp
3.08%
UBS Group AG
1.06%
See all

Insights on Vaxcyte Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PCVX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PCVX stock has moved up by 8.4%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PCVX has outperformed top 5 stocks with highest market-cap in its industry

About Vaxcyte Inc.

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
OrganisationVaxcyte Inc.
Headquarters825 Industrial Road, San Carlos, CA, United States, 94070
IndustryBiotechnology
CEOMr. Grant E. Pickering M.B.A.
E-voting on sharesClick here to vote

Key Management of Vaxcyte Inc.

Name

Title

Mr. Grant E. Pickering M.B.A.

Co-Founder, CEO & Director

Mr. Harp Dhaliwal M.B.A.

Chief Technical Operations Officer

Ms. Elvia Cowan

Senior VP of Finance & Chief Accounting Officer

Mr. Jeff Macdonald

Executive Director of Investor Relations

Ms. Janet Graesser

Senior Vice President of Corporate Affairs

Mr. Andrew L. Guggenhime M.B.A.

President & CFO

Mr. James T. Wassil M.B.A., M.S.

Executive VP & COO

Mr. Mikhail Eydelman J.D.

Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary

Dr. Jeff Fairman Ph.D.

Co-Founder & VP of Research

Ms. Whitney Jones

Chief People Officer

FAQs

What is Vaxcyte Inc. share price today?

Vaxcyte Inc. share price today is $51.44 as on at the close of the market. Vaxcyte Inc. share today touched a day high of $53.48 and a low of $50.24.

What is the 52 week high and 52 week low for Vaxcyte Inc. share?

Vaxcyte Inc. share touched a 52 week high of $65 on and a 52 week low of $29.08 on . Vaxcyte Inc. stock price today i.e. is closed at $51.44,which is 20.86% down from its 52 week high and 76.89% up from its 52 week low.

What is Vaxcyte Inc.'s market capitalisation today?

Vaxcyte Inc. market capitalisation is $0.01T as on .

How to invest in Vaxcyte Inc. Stock (PCVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vaxcyte Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vaxcyte Inc. Shares that will get you 0.0292 shares as per Vaxcyte Inc. share price of $51.44 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Vaxcyte Inc. Stock (PCVX) from India?

Indian investors can start investing in Vaxcyte Inc. (PCVX) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Vaxcyte Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Vaxcyte Inc. share’s latest price of $51.44 as on June 19, 2026 at 8:45 am IST, you will get 0.1944 shares of Vaxcyte Inc.. Learn more about fractional shares .

What are the returns that Vaxcyte Inc. has given to Indian investors in the last 5 years?

Vaxcyte Inc. stock has given 139.48% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?